MN HF648

Health plan companies cannot place lifetime or annual limits on screenings and urinalysis testing for opioids for enrollees in substance use disorder treatment programs when ordered by a health care provider and performed by accredited clinical laboratories.

Health plans may still conduct medical necessity reviews when opioid testing exceeds 24 tests in any 12-month period.

Medical assistance programs must cover screening and urinalysis tests for opioids without lifetime or annual limits.

The prohibition does not apply to managed care plans or county-based purchasing plans providing coverage to public health care program enrollees under chapters 256B or 256L.

The bill is effective January 1, 2022, and applies to health plans offered, issued, or renewed on or after that date.